Neuromuscular Ultrasound in ALS

Completed

Conditions studied: ALS

In brief

Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease affecting motor neurons. Early diagnosis is essential for the success of clinical trials and objective biomarkers are needed for monitoring disease progression. Nerve and muscle ultrasound may provide this information. This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to identify and monitor disease progression in ALS.

Key facts

Study ID

NCT01785550

Run by

Duke University

People needed

40

Starts

2013-02-01

Expected to finish

2015-03-01

Last updated by the study team

2015-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects referred to the electromyography laboratory for ALS.

You may not qualify if…

• Patients with known comorbid myopathy or neuropathy will be excluded from the study.
• Patients unable to provide their own consent will be excluded.

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.